10.21147/j.issn.1000-9604.2022.05.03
Comments on National guidelines for diagnosis and treatment of breast cancer 2022 in China(English version)
China is facing growing number of cancer cases and deaths,as well as growing crude incidence and mortality of cancer.Breast cancer is the most common cancer type in females in China and the incidence rate for breast cancer in Chinese females has increased during the last two decades.However,breast cancer prognosis in China is poorer than that in developed countries.Population aging may at least partially explain the transition of cancer profiles we have seen in recent years.Breast cancer screening technologies and public healthcare strategies targeting the high-risk population are being developed to reduce the cancer burden in China.
national、english、cancer、china、breast、comments、diagnosis、guidelines、treatment、version
34
S;H313;G2
2022-12-15(万方平台首次上网日期,不代表论文的发表时间)
共2页
451-452